Document is current
Any future updates will be listed below
-
Authors
Gamper, Eva M. https://orcid.org/0000-0002-1700-4054
Musoro, Jammbe Z.
Coens, Corneel
Stelmes, Jean-Jacques
Falato, Claudette
Groenvold, Mogens
Velikova, Galina
Cocks, Kim
Flechtner, Hans-Henning
King, Madeleine T.
Bottomley, Andrew
,
-
Funding
Funding for this research was provided by:
European Organisation for Research and Treatment of Cancer
- License Information
-
More Information
Article History
Received: 26 March 2021
Accepted: 16 July 2021
First Online: 7 October 2021
Declarations
:
: This is a retrospective analyses of two EORTC trials (EORTC 22961 and EORTC 22991). Approval for the study was waived by EORTC headquarter. The use of the patient data from the various studies fell under their original informed consent wording and no additional patient consent was needed from patient or local ethical committees. Data sharing and analysis was carried out under the General Data Protection Regulation of the European Union.
: Not applicable.
: No author reports any competing interests. Jammbe Z Musoro, Corneel Coens, Claudette Falato and Andrew Bottomley are employed by the European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.Dr. Velikova reports personal fees from Roche, personal fees from Eisai, personal fees from Novartis, grants from Breast Cancer Now, grants from EORTC, grants from Yorkshire Cancer Research, grants from Pfizer, outside the submitted work.Dr. Gamper reports grants from EORTC, outside the submitted work.
